Stemona root is a leukogenic drug, which can promote the proliferation of bone marrow tissue, thus increasing white blood cells. Used for leukopenia. It can increase white blood cells in peripheral blood. Animal experiments show that it can obviously prevent leukopenia caused by mitomycin, but it does not inhibit the anticancer effect of mitomycin. Its mechanism of action is to promote the proliferation of bone marrow tissue, thereby increasing white blood cells. It can be used for agranulocytosis caused by tumor radiotherapy and chemotherapy and leukopenia caused by other reasons.
On May 10, 2022, a new drug for treating COVID-19 discovered by Chinese scientists won the national invention patent. The patent specification shows that 10μM (micromole/L) cepharanthine inhibits coronavirus replication 15393 times. It can be understood that a small amount of cepharanthine can prevent the amplification and spread of COVID-19, and this drug ranks first in the ability to inhibit COVID-19 among all COVID-19 inhibitors discovered by human beings.
Learning history:
On May 10, 2022, a new drug for treating COVID-19 discovered by Chinese scientists won the national invention patent. The patent specification shows that 10μM (micromole/L) cepharanthine inhibits coronavirus replication 15393 times. It can be understood that a small amount of cepharanthine can prevent the amplification and spread of COVID-19, and this drug ranks first in the ability to inhibit COVID-19 among all COVID-19 inhibitors discovered by human beings.
American scholars have previously published papers in the journal Science, confirming that the data of cepharanthine is outstanding among the 26 drugs they studied, which is better than those of Remdesivir and Paroved that have been approved for marketing. Cepharanthine, also known as cepharanthine; Stephania; Stephanine, etc.